ReviewEnvironmental epigenetics2026
Environmental exposures and epigenetic alterations in common chronic diseases: insights and challenges.
Review in Environmental epigenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Exposure to environmental factors including contaminants and social conditions is implicated in a substantial proportion of common non-communicable diseases, and data from model systems repeatedly demonstrate that the process from environmental contributions to common chronic disease risk is mediated through maladaptive epigenetic responses. The field of environmental epigenetics leverages multiple disciplines to advance our understanding of environmental impacts on epigenomic processes to enhance etiologic investigation, guide biomarker discovery, and identify mechanisms of action that ultimately lead to behavioral and or therapeutic interventions. This article discusses examples of emerging research on the links between three common life course exposures linked to common non-communicable diseases, and their associated epigenetic modifications, with a major focus on DNA methylation-the most studied in humans. It also outlines current challenges when interpreting the accumulating body of knowledge, including the lack of consensus on regions reported to be targeted by these environmental exposures. Finally, given that the strongest predictors of epigenetic states are age and cell/tissue type, strategies to build novel platforms using existing technologies to surmount some of these challenges are discussed. Together, these advances in environmental epigenetics are paving the way for groundbreaking developments toward improved precision in developing prevention and intervention strategies to reduce common non-communicable disease morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.